Lv1
60 积分 2026-01-14 加入
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction–associated steatohepatitis (MASH) and fibrosis
3天前
已完结
Preclinical stages of Crohn's disease defined by faecal calprotectin in asymptomatic first-degree relatives
27天前
已关闭
The questionable role of immunization against hepatitis B in HBV infected liver transplant patients
1个月前
已完结
皖公网安备34019202002308
